Robert Bazemore

CEO Steps Down as Epizyme Finalizes 5-Year Growth Strategy
BioSpace
Tue, 08/10/21 - 11:15 pm
Epizyme
Pharma CEOs
Robert Bazemore
For Epizyme chief executive, the work is personal
Boston Globe, MA
Sun, 12/6/15 - 10:18 am
Epizyme
non-Hodgkin’s lymphoma
Robert Bazemore